NIH-funded research R01 grant

Helping Young Cancer Patients Manage Their Symptoms Better

Official title: A Randomized Controlled Trial using a Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults with Cancer

Funded at Virginia Commonwealth University · NIH-11136270 · Data updated 2026-11-12

This project helps young people with cancer learn to manage their symptoms better using a special computer tool.

More Randomized Controlled Trial research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVirginia Commonwealth University
NIH-funded
Lab location1 site (Richmond, United States)
Project startJune 9, 2023
Project endMay 31, 2027
Funding year2025
Award (this year)$568,771
NIH project number5R01CA286799-03
Project IDNIH-11136270 on NIH RePORTER

Who could benefit from this research

Could help

This project is for adolescents and young adults who have cancer and are currently receiving active treatment.

Less likely to help

Patients who are not adolescents or young adults, or who are not actively undergoing cancer treatment, would likely not be eligible for this specific project.

What this research studies

Adolescents and young adults (AYAs) with cancer often struggle with many symptoms from their disease and treatment, which can make daily life hard. This project is testing a new computer tool called C-SCAT that helps you understand your symptoms and how they connect. It's different from typical checklists because it focuses on what's most important to you and helps you visualize your unique symptom experience. The C-SCAT also helps you talk with your doctor about your top concerns and create a personalized plan to manage your symptoms.

Why it matters

Potential benefit: If successful, this tool could help young cancer patients feel better and have a higher quality of life by giving them more control over their symptoms.

How similar studies have gone: This project addresses a gap by testing a new intervention tailored to this population, suggesting it's a novel approach for AYA symptom self-management.

Where this research is happening

  • Virginia Commonwealth University
    Richmond, United States
    Active

Researchers

  • Principal investigator: Elswick, Ronald K. — Virginia Commonwealth University
  • Study coordinator: Elswick, Ronald K.

Related research

Other NIH-funded projects on the same topics.

  • Heuristic tool helps adolescents and young adults with cancer manage symptoms

    A randomized trial tests a computer-based symptom tool to help teens and young adults with cancer manage their symptoms with their care team.

    NIH research Virginia Commonwealth University · Richmond, United States · NIH-11376165

  • A digital game to help heart failure patients manage their health

    This study is testing a fun digital game that uses sensors to help heart failure patients manage their health better by giving them personalized feedback and rewards for keeping track of their weight and staying active.

    NIH research University of Texas at Austin · Austin, United States · NIH-10983787

  • A digital tool to help adolescents manage their migraines.

    This study is testing a helpful app for teenagers with migraines that teaches them how to take better care of themselves by focusing on things like drinking enough water, eating well, staying active, and getting good sleep, all while providing support to help them stick with it.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-10831483

  • Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure

    A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.

    NIH research Pennsylvania State Univ Hershey Med Ctr · Hershey, United States · NIH-11635771

  • Shorter antifungal treatment for kids with candidemia

    A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606539

  • Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia

    This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606535

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.